1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6DE1CF4DEA7EF55EA0025870C006A4FD6
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-leveraging-outcomes-data-structure-collaboration-health-economics-outcomes-research-oncology-products?opendocument
18
19opendocument
203.239.58.199
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Health Outcomes

Leveraging Outcomes Data – Structure and Collaboration in Health Economics & Outcomes Research in Oncology Products

ID: 5686


Features:

6 Info Graphics

24 Data Graphics

400+ Metrics


Pages/Slides: 36


Published: 2021


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Leveraging Outcomes Data: Structure and Collaboration in Health Economics & Outcomes Research in Oncology Products"


STUDY OVERVIEW


Demonstrating an oncology drug’s value proposition and its potential in real-world practice will maximize business and clinical success. The Health Economics Outcomes Research function is a key player in generating value-oriented outcomes data, but it needs to effectively collaborate with other groups to leverage the information

This study illustrates the strategies for effective health outcomes data communication and utilization and how HEOR collaborates with key internal stakeholders.

Segmentation based on two areas: Geographic responsibility and HEOR reporting structure

KEY TOPICS

  • Executive Summary: Methodology, Participants, & Key Findings
  • HEOR Structure, Collaboration and Involvement
KEY METRICS

I. Structure

  • Structure of Health Economics and Outcomes Research (HEOR) group within the organization
  • Internal HEOR collaboration – Global vs. U.S. Only
  • HEOR involvement vs. effectiveness for value delivery
  • Effectiveness of HEOR function at delivering value in the listed areas to the company – Market Access vs. Medical Affairs and Global vs. U.S.
  • Highly effective HEOR functions for delivering value
  • Health outcomes data usage vs. effectiveness
  • Utilization of listed types of health outcomes activities by the HEOR function – Market Access vs. Medical Affairs and Global vs. U.S.
  • Effectiveness of health outcomes activities to inform key decisions within the company
  • Level of HEOR’s involvement in each of the listed activities
  • Sharing of medical information with various groups
  • Organization’s role in collecting the listed types of health outcomes data – Global vs. U.S. Only and Market Access vs. Medical Affairs
  • Preferred frequency of communications (at a country & region level) with internal staff – Global vs. U.S. Only and Market Access vs. Medical Affairs
  • Preferred frequency of communications (at a country & region level) with internal staff – Market Access vs. Medical Affairs
  • Roles played by HEOR team in carrying out activities designed to probe (payers) stakeholders’ needs and perspectives

SAMPLE KEY FINDINGS

  • Structure: Global HEOR groups sit more often in Market Affairs; U.S. HEOR responsibilities are shared between Market Access and Medical Affairs.
METHODOLOGY

Conducted an operational HEOR benchmark analysis engaging 27 HEOR leaders working across 19 top life-science companies. Report segments included geographic responsibility and functional reporting structure.


Industries Profiled:
Pharmaceutical; Consumer Products; Biotech; Health Care; Laboratories; Diagnostic; Communications; Biopharmaceutical


Companies Profiled:
AbbVie; Merck Serono; Novartis; Astellas; Boehringer Ingelheim; Pfizer; Eisai; Takeda Pharmaceuticals; Ipsen; Merck Sharp & Dohme; Daiichi Sankyo; Alkem; Foundation Medicine; Sun Pharmaceutical; Karyopharm Therapeutics; Brii Biosciences; Nucleus Global; Seattle Genetics

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.